drugset / Trial / NCT03154619
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The safety and efficacy of beta glucan products, and specifically TR 987, in the treatment of chronic venous insufficiency ulcers has been established. This study is designed to determine the most efficient method of treatment.
Timeline
- Start
- 2016-11
- Primary completion
- 2019-04-04
- Completion
- 2021-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | beta-glucan | Other / unclassified | 0.1 % | Topical |